June 20, 2023 Pediatric Obesity Research Update | Once-Weekly Semaglutide in Adolescents with Obesity Share this post Each month, the OMA Pediatric Committee reviews a pediatric-focused obesity research update to help keep you up to date about the latest findings
Patients need ongoing guidance, clear progress tracking, structured coaching touchpoints, and easy access to their care plan
Ozempic (semaglutide) is licensed only for type 2 diabetes treatment, not for weight loss
How do psychological changes in opioid use disorder affect patient behavior and treatment planning
Both strategies boost metabolic rate and muscle heat production, counteracting the thermogenic reduction from semaglutide
Discussion Liver is an important organ involved in several activities, including bile acid secretion, the generation of blood clotting factors and detoxification